beroe-ai

Consumer Healthcare
Market, Supplier, Risk and
Competitive Intelligence

best-value

With this purchase you will be subscribed for a 12-month PRO membership to AI Powered Procurement Productivity Suite - Beroe LiVE.Ai

feature

 No Additional Benefits

Subscription Benefits:

  • PRO access to New Beroe LiVE*
  • Category Report with unlimited updates*
  • Supplier Watchlist for 3 suppliers*
  • Supplier Shortlisting Tool*

With this purchase you will be subscribed for a 12-month PRO membership to AI Powered Procurement Productivity Suite - Beroe LiVE.Ai

feature

Manage Consumer Healthcare Category with Ai powered
Procurement Productivity Suite

meet-abi-1

Abi will answer all Consumer Healthcare related
procurement queries with relevant data points

Abi - AI powered digital procurement assistant

discover-market-info

Get up-to-date market and supplier info on Consumer Healthcare to help you build

Intelligence covers market and price outlook, SWOT analysis, demand & supply drivers, engagement models and Procurement best practices

1

Intelligence on category covers the following aspects market outlook, supply market, SWOT analysis, Cost components & Price outlook, Demand and supply drivers, Engagement Models and Procurement Best Practices

manage-risk

Assess Supplier Risk based on key risk and compliance parameters

1

Supplier assessment covers the following parameters Financial Risk, Ethical, Labor, Environmental Compliance, IT Security.

2

Supplier assessment is powered by world’s leading data partners including D&B, CreditSafe, Dow Jones, Refinitiv, Orpheus

discover-supplier

Identify right fit suppliers based on your selection criteria including revenue, capabilities, certification, geography

1

Select suppliers based on industry, country, classification from a database of 4.2 mn suppliers. Get detailed supplier profiles with supplier capabilities, revenue, certifications, risk ratings

assess-category-perforamnce

Benchmark your category performance against peers and the market

1

Measure category performance on 15 key parameters across cost, risk and strategy KPIs

source-market-indices

Get information on key factors affecting your supply

1

Source Macro Data and Market Indices information from leading data sources across these key areas - Labor Rates, Currency, Energy, Country Risk, Trade Flow/Transportation, Port Data, Tariff, Weather and Epidemics

meet-abi-1

Abi will answer all Consumer Healthcare related
procurement queries with relevant data points

Abi - AI powered digital procurement assistant

discover-market-info

Get up-to-date market and supplier info on Consumer Healthcare to help you build

Intelligence covers market and price outlook, SWOT analysis, demand & supply drivers, engagement models and Procurement best practices

1

Intelligence on category covers the following aspects market outlook, supply market, SWOT analysis, Cost components & Price outlook, Demand and supply drivers, Engagement Models and Procurement Best Practices

manage-risk

Assess Supplier Risk based on key risk and compliance parameters

1

Supplier assessment covers the following parameters Financial Risk, Ethical, Labor, Environmental Compliance, IT Security.

2

Supplier assessment is powered by world’s leading data partners including D&B, CreditSafe, Dow Jones, Refinitiv, Orpheus

discover-supplier

Identify right fit suppliers based on your selection criteria including revenue, capabilities, certification, geography

1

Select suppliers based on industry, country, classification from a database of 4.2 mn suppliers. Get detailed supplier profiles with supplier capabilities, revenue, certifications, risk ratings

assess-category-perforamnce

Benchmark your category performance against peers and the market

1

Measure category performance on 15 key parameters across cost, risk and strategy KPIs

source-market-indices

Get information on key factors affecting your supply

1

Source Macro Data and Market Indices information from leading data sources across these key areas - Labor Rates, Currency, Energy, Country Risk, Trade Flow/Transportation, Port Data, Tariff, Weather and Epidemics

Get Beroe LiVE.Ai subscription for your team

17k + companies trust Beroe for their supply market intelligence needs

Check out what’s included in market information for Consumer Healthcare on Beroe LiVE.Ai

Learn More about Beroe LiVE.Ai

Report Coverage

  • Regulatory Trends
  • Market Trends: Current Developments
  • Competitor Analysis–Overall Consumer Healthcare

Market Size

Global Market Size

$313.2 Billions

Market Size Europe

$208.95 Bn

Market Size Asia Pacific

$144.10 Bn

CAGR

6.8 Percent

Table of contents

  1. Executive Summary
  2. Executive Summary
  3. Impact of COVID-19 on Consumer Healthcare
  1. COVID-19 Impact
  2. COVID-19 Impact -Industry Watch
  3. COVID-19 Impact -Sourcing Location Watch
  4. COVID-19 Impact -Supplier Watch

 

  1. Market Analysis
  2. Global Market Size and Growth Forecast
  3. Regulatory Trends
  4. Market Trends
  5. Porter’s Five Forces Analysis
  6. Growth Drivers and Constraints

 

  1. Market Monitoring Insights
  2. Cost Drivers and Cost Structure

 

  1. Sourcing Practices
  2. Sourcing Model
  3. Outsourcing Adoption Rate

 

  1. Supplier Section
  2. Key Global Suppliers
  3. GlaxoSmithKline plc
  4. Sanofi
  5. Novartis AG
  6. Bayer AG
  7. Abbott

Want a more detailed personalised report?

Global Market Outlook on Consumer Healthcare Services

  • Consumer health products do not require a written prescription from healthcare professionals but can be purchased directly from a pharmacy store
  • Factors like the increasing use of online resources and e-commerce websites will aid the prospects for consumer healthcare market size growth
  • For instance, websites such as healthkart.com, vitacost.com, and vivavitamins.com offer a wide array of vitamin health drinks, protein shakes, and supplements online. Also, these sites offer live interactive chat sessions to provide instant support to individuals who face challenges while purchasing such products
  • This recent shift toward the use of e-commerce websites and online resources is expected to drive the market growth for consumer healthcare products during the forecast period

Consumer Healthcare Industry Analysis

Regional Market Analysis

North America and Europe

  • Major pharmaceutical, consumer products, medical device manufacturing companies, CRAMS organizations and health insurance companies are located here. In September 2016, the Senate Committee announced the need to explore FDA's mandates on safety of cosmetics, and if the current regulations are in par to provide 100 percent consumer safety and has been issuing regulations on various consumer products relating to chemical poisoning, manufacturing practices and its impact on consumer health
  • The European Commission's (EC) Chemical regulation body, European Chemicals Agency (ECHA) is focused on testing and evaluation of chemicals and entities under REACH, to evaluate the effect of these substance on people and aims to fill and update the gaps in dossiers to improve the data quality

Japan

  • Since the former ‘Pharmaceutical Affairs Act' unified manufacturing and sales in Japan until 2005, Japan was not fertile soil for CMOs to develop. Once manufacturing and sales were recognized as separate by the ‘ Revised Pharmaceutical Affairs Act' , the Japanese CRO/CMO market has been growing ever

Asia Pacific

  • Due to the lower cost of manufacturing and labor, with a large number of GMP facilities, less regulatory complications, Asia Pacific is growing rapidly
  • China has approved and paved way for a series of GMO crops. Seed companies have complained that china's regulatory process is slow and this news means there is a hope for the companies to expand and gain access to markets

ROW

  • Latin America drives the market, as most of the Consumer Healthcare Products Manufacturer's are trying to penetrate the growing market by localizing the products
  • Couple of A&Ms are also taking place in this region among CRAMS & Consumer Healthcare. There is not much growth in other regions, like Africa and the Middle East

Outsourcing Adoption Rate

Companies are looking for ways to reduce costs, to overcome capacity constraints, to minimize fixed costs, minimize product-market cycle times and to achieve capital efficiency. Further, these companies are extending their global foot prints and try to localize their products. These companies, therefore, are turning to value-based outsourcing and becoming ‘Consumer Centric’. Key Outsourcing Consumer Healthcare MarketTrends

  • Increasing R&D Failures
  • Capital Efficiency (30-50 percent Cost Optimization)
  • Global Footprints and Localization
  • Capacity Constraints for product & line extensions and new products
  • New Product Development & Delivery Systems Technologies for product differentiation
  • Value added generics
  • Emerging Markets
  • Need for operational excellence in terms of GMP and regulatory compliance
  • Need for integrated & specialty services
  • Need for cost efficiencies due to patent expirations and increasing generics competition
  • Access to proprietary technologies for achieving product differentiation

Regulatory Trends

Regulatory paradigms that are evolving at regional level and changing worldwide

  • Evolving of defined and transparent regulatory guidelines for prescription, OTC, dietary supplements, nutritional products etc
  • Regulatory frame work for controlling each & every function research, manufacturing, quality control, labeling, packaging, storage and distribution, logistics etc.
  • Regulatory framework for proof of efficacy and safety
  • Restrictions on animal testing
  • Restrictions on the usage of certain packaging components like plastics for liquids
  • Post-marketing vigilance onthe efficacy & safety
  • Anti-counterfeiting measures throughout the ‘supply chain management

Growth Drivers and Constraints

The availability of low cost drugs to the public is a driving force for the emerging consumer healthcare market.

Drivers

  • Entry of CPG Companies
  • Need for cost efficiencies due to patent expirations and increasing generics competition
  • Access to proprietary technologies for achieving product differentiation
  • Leverage of external R&D sources between companies and service providers
  • Value-based-payment Models
  • Entry of numerous small, virtual start-ups having little market that have no manufacturing capacity and product development experience.
  • Government Policies to provide ‘Affordable Healthcare & Easy Access to Healthcare'

Constraints

  • Increasing ‘Regulatory Framework' across the regions.
  • Burden of proof w.r.t. health benefit claims and safety esp. in EU
  • Prevention of abuse and misuse by the consumers
  • Counterfeiting Prevention
  • A&M of Vendors with Global CMO Companies thereby minimizing business opportunities and affecting Consumer Healthcare Market-R&D

Market Trends

The consumer healthcare market remains highly competitive and fragmented albeit leading companies continuing to consolidate their market position through high-profile and strategic acquisitions.

  • A positive regulatory outlook in key markets, due to new initiatives and frameworks looking to facilitate OTC approvals, will also prompt companies to seek access to new markets.
  • Drug manufacturers, regulators, and consumers are increasing pressure on pharma companies to make the Rx-to-OTC switch, as non-prescription medications are cheaper and easier to access.
  • Beyond basic efficacy data, potential benefits of a switch could include increased access to treatment options, improved quality of life, improved public health, enhanced consumer awareness and involvement, or greater worker productivity
  • An increasing interest in self-medication in both developed and developing countries has been identified as a major contributor to market growth in recent years
  • M&A is expected to remain very active in the coming years fueled by strategic long-term commercial priorities, as companies look to increase revenues through expanded product portfolios.
  • The industry is adapting to a value driven portfolio compared to volume-based approach focusing on benefits over price premium, capitalizing on consumers’ informed peer driven choices.
  • This has put global players in a situation to meet fast emerging consumer needs while maintaining the quality in a continuously evolving global regulatory landscape

Consumer Healthcare Market Frequently Asked Questions

  1. What is the average market size of different continents within the consumer healthcare market?
  2. As per Beroe’s analysis, the consumer healthcare market size of different continents like North America, Europe, Asia Pacific, and Latin America is $266.59 Bn, $208.95 Bn, $144.10 Bn, and $100.87 Bn respectively.

 

  1. What are the common drugs consumers with gastrointestinal conditions rely on?
  2. Consumers suffering from mild gastrointestinal conditions usually rely on drugs like laxatives, antidiarrheals, and digestives. 

 

  1. How will the practice of self-medication benefit the consumer healthcare market?
  2. The practice of self-medication reduces the pressure on medical services and patients living in rural areas can easily access it. Further, it will also positively affect the market beyond 2020.

 

  1. Who are the key suppliers in the consumer healthcare industry?
  2. As per the insights from Beroe’s report, the key suppliers of the consumer healthcare market are: Myoderm Piramal Healthcare Catalent Inc. Quantex Recipharm ABCO Laboratories, Inc. Zeon Lifesciences North Carolina Clinical Research Novex Clinical Research Covance  

 

  1. How is the consumer healthcare market categorized regionally between the US, Europe, and APAC?
  2. From Beroe’s report, one can conclude that the US and Europe are the major markets for consumer healthcare products, whereas, APAC is growing rapidly at a CAGR of 18 percent. 

 

  1. Discuss the pricing and engagement model prevalent within the consumer healthcare market?  
  2. As per the consumer healthcare market report shared by Beroe, the volume-based model is the most preferred model in the consumer healthcare market, while the service-based model is alternatively preferred by the consumers. Similarly, the FTE model is more preferred when it comes to pricing, while FFS and fixed-unit price are alternate models prevalent within the consumer healthcare market.

 

  1. What are the common outsourcing trends applicable within the consumer healthcare market?
  2. Following the data from Beroe’s report, with a shift in buyer trend and increasing outsourcing of consumer healthcare services, the suppliers are expanding their capacities. Similarly, strategic partnerships between CROs and big consumer healthcare companies will drive flexibility, reduce costs, and extend expertise.  

 

  1. What are the four drivers that influence the consumer healthcare market?
  2. As per Beroe’s report, the following are the main drivers of the consumer healthcare market: Increasing use of online resources and e-commerce websites Self-medication Aging population Focus on wellness   

 

  1. Are there any constraints that apply to the consumer healthcare market?
  2. The following three constraints are prevalent within the market: Increasing regulatory framework across the regions Prevention of abuse and misuse by the consumers Counterfeiting prevention   

 

  1. What’s the sole driving force for the emerging consumer healthcare market?  
  2. As per the global consumer healthcare market, the availability of low-cost drugs to the public is the main driving force for the emerging consumer healthcare market.

With this purchase you will be subscribed for a 12-month PRO membership to AI Powered Procurement Productivity Suite - Beroe LiVE.Ai

feature

Complimentary 12-month access to Beroe LiVE

Any more questions?

Get in touch with us quickly and easily.

x

COVID-19: Assess impact on your suppliers and ensure business continuity with Beroe’s WIRE
(World Instant Risk Exposure)